Peripheral Beta-2 Adrenergic Receptors Mediate the Sympathetic Efferent Activation from Central Nervous System to Splenocytes in a Mouse Model of Fibromyalgia.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
09 Feb 2023
Historique:
received: 24 11 2022
revised: 30 01 2023
accepted: 06 02 2023
entrez: 25 2 2023
pubmed: 26 2 2023
medline: 3 3 2023
Statut: epublish

Résumé

Abnormalities in the peripheral immune system are involved in the pathophysiology of fibromyalgia, although their contribution to the painful symptoms remains unknown. Our previous study reported the ability of splenocytes to develop pain-like behavior and an association between the central nervous system (CNS) and splenocytes. Since the spleen is directly innervated by sympathetic nerves, this study aimed to examine whether adrenergic receptors are necessary for pain development or maintenance using an acid saline-induced generalized pain (AcGP) model (an experimental model of fibromyalgia) and whether the activation of these receptors is also essential for pain reproduction by the adoptive transfer of AcGP splenocytes. The administration of selective β2-blockers, including one with only peripheral action, prevented the development but did not reverse the maintenance of pain-like behavior in acid saline-treated C57BL/6J mice. Neither a selective α1-blocker nor an anticholinergic drug affects the development of pain-like behavior. Furthermore, β2-blockade in donor AcGP mice eliminated pain reproduction in recipient mice injected with AcGP splenocytes. These results suggest that peripheral β2-adrenergic receptors play an important role in the efferent pathway from the CNS to splenocytes in pain development.

Identifiants

pubmed: 36834875
pii: ijms24043465
doi: 10.3390/ijms24043465
pmc: PMC9967679
pii:
doi:

Substances chimiques

Receptors, Adrenergic, beta-2 0
Receptors, Adrenergic 0
Receptors, Adrenergic, beta 0
Adrenergic beta-Antagonists 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Ministry of Education, Culture, Sports, Science and Technology
ID : JP21H03024
Organisme : Nakatomi Foundation
ID : to Hisashi Shirakawa
Organisme : Takeda Science Foundation
ID : to Hisashi Shirakawa

Références

J Pain. 2007 May;8(5):422-9
pubmed: 17293165
Neurochem Int. 2016 Dec;101:144-155
pubmed: 27840124
Front Neurosci. 2020 Dec 23;14:600166
pubmed: 33424538
Ann Neurol. 2014 Feb;75(2):196-208
pubmed: 24243538
Pharmacol Rev. 2000 Dec;52(4):595-638
pubmed: 11121511
FEBS J. 2017 Sep;284(18):3018-3028
pubmed: 28710773
Front Biosci (Landmark Ed). 2009 Jun 01;14(14):5291-338
pubmed: 19482616
Mol Imaging Biol. 2005 Jan-Feb;7(1):37-44
pubmed: 15912274
Exp Neurol. 2010 Jan;221(1):115-21
pubmed: 19840789
Iran J Basic Med Sci. 2020 Jul;23(7):894-900
pubmed: 32774811
J Pain. 2009 Sep;10(9):895-926
pubmed: 19712899
Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):11008-13
pubmed: 18669662
Pharmacol Rev. 2001 Dec;53(4):487-525
pubmed: 11734616
J Neurosci. 2011 Feb 9;31(6):2258-70
pubmed: 21307262
Isr Med Assoc J. 2008 Jan;10(1):77-8
pubmed: 18300581
Int J Mol Sci. 2015 Mar 11;16(3):5635-65
pubmed: 25768345
Nat Rev Dis Primers. 2015 Aug 13;1:15022
pubmed: 27189527
Pain. 2009 Nov;146(1-2):26-33
pubmed: 19646816
Anesthesiology. 2018 Aug;129(2):343-366
pubmed: 29462012
Pharmacol Rev. 1973 Sep;25(3):373-413
pubmed: 4147908
Auton Neurosci. 2014 May;182:15-41
pubmed: 24685093
Neuroimmunomodulation. 2012;19(6):343-51
pubmed: 22986514
Med Sci Monit. 2018 Feb 27;24:1196-1204
pubmed: 29485127
Muscle Nerve. 2001 Jan;24(1):37-46
pubmed: 11150964
Eur J Pharmacol. 1994 Sep 12;262(3):283-6
pubmed: 7813593
Pain. 2005 Jul;116(1-2):79-86
pubmed: 15936144
Int J Mol Sci. 2021 Apr 09;22(8):
pubmed: 33918736
Cell Death Dis. 2013 Mar 07;4:e525
pubmed: 23470532
Clin Exp Rheumatol. 2021 Jan-Feb;39(1):21-31
pubmed: 32083545
Brain Behav Immun. 2019 Jan;75:72-83
pubmed: 30223011
J Rheumatol. 2004 Feb;31(2):364-78
pubmed: 14760810
J Formos Med Assoc. 2021 Aug;120(8):1611-1619
pubmed: 33642123
Mol Pain. 2008 Nov 06;4:52
pubmed: 18990235
J Physiol. 2016 Oct 15;594(20):5781-5790
pubmed: 27059884
J Neurosci. 2010 Aug 4;30(31):10360-8
pubmed: 20685979
Annu Rev Pharmacol Toxicol. 1995;35:417-48
pubmed: 7598501
Pain Med. 2011 Aug;12(8):1154-61
pubmed: 21714842
BMC Vet Res. 2020 Jul 14;16(1):242
pubmed: 32660541
Mol Pain. 2014 Jun 23;10:40
pubmed: 24957987
Brain Res Bull. 1981 Jan;6(1):83-94
pubmed: 7193506
J Pharmacol Exp Ther. 1999 Jul;290(1):241-6
pubmed: 10381782
Brain Behav Immun. 2011 Mar;25(3):503-13
pubmed: 21134441
J Neurophysiol. 1999 Mar;81(3):1104-12
pubmed: 10085337
Brain Behav Immun. 1989 Dec;3(4):291-311
pubmed: 2575409
J Neurosci. 1998 Apr 15;18(8):3043-9
pubmed: 9526021
Autoimmun Rev. 2018 Jan;17(1):53-72
pubmed: 29108826
Clin Exp Rheumatol. 2020 Nov-Dec;38(6):1275
pubmed: 33275092
Neurobiol Pain. 2017 Apr 17;1:16-25
pubmed: 31194005
Biomed Pharmacother. 2021 Dec;144:112331
pubmed: 34673421
J Clin Med. 2020 Jun 10;9(6):
pubmed: 32532082

Auteurs

Shiori Yamashita (S)

Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, 46-29 Yoshida-Shimoadachi-cho, Sakyo-ku, Kyoto 606-8501, Japan.

Naoki Dozono (N)

Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, 46-29 Yoshida-Shimoadachi-cho, Sakyo-ku, Kyoto 606-8501, Japan.
Department of Pharmacology and Therapeutic Innovation, Nagasaki University Institute of Biomedical Sciences, Nagasaki 852-8521, Japan.

Shota Tobori (S)

Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, 46-29 Yoshida-Shimoadachi-cho, Sakyo-ku, Kyoto 606-8501, Japan.

Kazuki Nagayasu (K)

Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, 46-29 Yoshida-Shimoadachi-cho, Sakyo-ku, Kyoto 606-8501, Japan.

Shuji Kaneko (S)

Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, 46-29 Yoshida-Shimoadachi-cho, Sakyo-ku, Kyoto 606-8501, Japan.

Hisashi Shirakawa (H)

Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, 46-29 Yoshida-Shimoadachi-cho, Sakyo-ku, Kyoto 606-8501, Japan.

Hiroshi Ueda (H)

Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, 46-29 Yoshida-Shimoadachi-cho, Sakyo-ku, Kyoto 606-8501, Japan.
Department of Pharmacology and Therapeutic Innovation, Nagasaki University Institute of Biomedical Sciences, Nagasaki 852-8521, Japan.
Graduate Institute of Pharmacology, National Defense Medical Center, Nei-hu, Taipei 114201, Taiwan.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH